BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2019
View Archived Issues
Targeted protein degradation with DGY-08-097 shows promise for hepatitis C virus treatment
Read More
Discovery and preclinical characterization of c-KIT kinase inhibitor CHMFL-KIT-64
Read More
Vulnerable brains can be steered towards healthy development
Read More
Four-way interaction screen gives clues to drug effects
Read More
FDA clears IND application for phase I/II study of OBI-999
Read More
Inhibrx announces phase I dose-escalation data for INBRX-109
Read More
Kura Oncology presents phase II results for tipifarnib in HRAS-mutant urothelial carcinoma
Read More
Positive phase II data presented for CTP-543 in patients with alopecia areata
Read More
TAS-4464 demonstrates potent antitumor activity in hematologic and solid tumor models
Read More
BMS-986235 shows efficacy in preclinical models of heart failure
Read More
Fulacimstat does not improve standard of care treatment in CHIARA MIA 2 study
Read More
Biogen explores non-covalent activation of NRF2 for neurodegenerative and other disorders
Read More
Machine learning from adversity speeds compound development
Read More
Discovery of a first-in-class dual adenosine A2A/A2B receptor antagonist
Read More
Phase III AMPLIFY study of phosphate absorption inhibitor tenapanor meets primary endpoint
Read More
Pfizer synthesizes new KRAS inhibitors
Read More
Positive preclinical data presented for Cocrystal Pharma's CC-42344
Read More
Turning Point Therapeutics reports new data on repotrectinib and TPX-0046
Read More
Medshine Discovery divulges kynurenine production inhibitors
Read More
Phase II trial of AR-105 for ventilator-associated pneumonia does not meet primary endpoint
Read More
Jiangsu Aosaikang Pharmaceutical identifies H+/K+ ATPase inhibitors
Read More
Beijing Scitech-Mq Pharmaceuticals describes RET and VEGFR2 inhibitors
Read More
InnoCare Pharma identifies TRK inhibitors
Read More
